New insight in the pathogenesis of functional gastrointestinal disorders: Association between genetics and colonic transit

Neurogastroenterology and Motility

Volumn 23, Issue 10, 2011, Pages 893-897

  Wouters, M M ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

C11orf30; CDH1; ORMDL3; PRDM1; TLR9

Indexed keywords

ARTICLE; AUTOPHAGY; CELIAC DISEASE; CLINICAL FEATURE; DIGESTIVE SYSTEM FUNCTION DISORDER; ENTERITIS; GENE LOCUS; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOME ANALYSIS; HUMAN; INNATE IMMUNITY; INTESTINE EPITHELIUM; PATHOGENESIS; PRIORITY JOURNAL; RISK FACTOR;

ANIMALS; GASTROINTESTINAL DISEASES; HUMANS;

EID: 80052835291     PISSN: 13501925     EISSN: 13652982     Source Type: Journal    
DOI: 10.1111/j.1365-2982.2011.01774.x     Document Type: Article

References (29)

1. Spiller RC, Jenkins D, Thornley JP et al. Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome. Gut 2000; 47: 804-11.
2. Cremon C, Gargano L, Morselli-Labate AM et al. Mucosal immune activation in irritable bowel syndrome: gender-dependence and association with digestive symptoms. Am J Gastroenterol 2009; 104: 392-400.
3. Barbara G, Stanghellini V, De GR et al. Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome. Gastroenterology 2004; 126: 693-702.
4. Schoepfer AM, Schaffer T, Seibold-Schmid B, Muller S, Seibold F. Antibodies to flagellin indicate reactivity to bacterial antigens in IBS patients. Neurogastroenterol Motil 2008; 20: 1110-8.
5. Cenac N, Chin AC, Garcia-Villar R et al. PAR2 activation alters colonic paracellular permeability in mice via IFN-gamma-dependent and -independent pathways. J Physiol 2004; 558: 913-25.
6. Gecse K, Roka R, Ferrier L et al. Increased faecal serine protease activity in diarrhoeic IBS patients: a colonic lumenal factor impairing colonic permeability and sensitivity. Gut 2008; 57: 591-9.
7. Nell S, Suerbaum S, Josenhans C. The impact of the microbiota on the pathogenesis of IBD: lessons from mouse infection models. Nat Rev Microbiol 2010; 8: 564-77.
8. Dubois PC, Trynka G, Franke L et al. Multiple common variants for celiac disease influencing immune gene expression. Nat Genet 2010; 42: 295-302.
9. Festen EA, Goyette P, Green T et al. A meta-analysis of genome-wide association scans identifies IL18RAP, PTPN2, TAGAP, and PUS10 as shared risk loci for Crohns' disease and celiac disease. PLoS Genet 2011; 7: e1001283.
10. Franke A, McGovern DP, Barrett JC et al. Genome-wide meta-analysis increases to 71 the number of confirmed Crohns' disease susceptibility loci. Nat Genet 2010; 42: 1118-25.
11. Barrett JC, Hansoul S, Nicolae DL et al. Genome-wide association defines more than 30 distinct susceptibility loci for Crohns' disease. Nat Genet 2008; 40: 955-62.
12. Anderson CA, Boucher G, Lees CW et al. Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47. Nat Genet 2011; 43: 246-52.
13. Wapenaar MC, Monsuur AJ, van Bodegraven AA et al. Associations with tight junction genes PARD3 and MAGI2 in Dutch patients point to a common barrier defect for coeliac disease and ulcerative colitis. Gut 2008; 57: 463-7.
14. Saito YA, Talley NJ. Genetics of irritable bowel syndrome. Am J Gastroenterol 2008; 103: 2100-4.
15. Yeo A, Boyd P, Lumsden S et al. Association between a functional polymorphism in the serotonin transporter gene and diarrhoea predominant irritable bowel syndrome in women. Gut 2004; 53: 1452-8.
16. Park JM, Choi MG, Park JA et al. Serotonin transporter gene polymorphism and irritable bowel syndrome. Neurogastroenterol Motil 2006; 18: 995-1000.
17. Saito YA, Locke GR III, Zimmerman JM et al. A genetic association study of 5-HTT LPR and GNbeta3 C825T polymorphisms with irritable bowel syndrome. Neurogastroenterol Motil 2007; 19: 465-70.
18. Lesch KP, Bengel D, Heils A et al. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 1996; 274: 1527-31.
19. Blom RM, Samuels JF, Riddle MA et al. Association between a serotonin transporter promoter polymorphism (5HTTLPR) and personality disorder traits in a community sample. J Psychiatr Res 2011; 45: 1153-9.
20. Jarrett ME, Kohen R, Cain KC et al. Relationship of SERT polymorphisms to depressive and anxiety symptoms in irritable bowel syndrome. Biol Res Nurs 2007; 9: 161-9.
21. Pata C, Erdal E, Yazc K, Camdeviren H, Ozkaya M, Ulu O. Association of the -1438G/A and 102 T/C polymorphism of the 5-Ht2A receptor gene with irritable bowel syndrome 5-Ht2A gene polymorphism in irritable bowel syndrome. J Clin Gastroenterol 2004; 38: 561-6.
22. Jun S, Kohen R, Cain KC, Jarrett ME, Heitkemper MM. Associations of tryptophan hydroxylase gene polymorphisms with irritable bowel syndrome. Neurogastroenterol Motil 2011; 23: 233-9.
23. Zucchelli M, Camilleri M, Nixon AA et al. Association of TNFSF15 polymorphism with irritable bowel syndrome. Gut 2011; [Epub ahead of print].
24. Aerssens J, Camilleri M, Talloen W et al. Alterations in mucosal immunity identified in the colon of patients with irritable bowel syndrome. Clin Gastroenterol Hepatol 2008; 6: 194-205.
25. Villani AC, Lemire M, Thabane M et al. Genetic risk factors for post-infectious irritable bowel syndrome following a waterborne outbreak of gastroenteritis. Gastroenterology 2010; 138: 1502-13.
26. Marenholz I, Bauerfeind A, Esparza-Gordillo J et al. The eczema risk variant on chromosome 11q13 (rs7927894) in the population-based ALSPAC cohort: a novel susceptibility factor for asthma and hay fever. Hum Mol Genet 2011; 20: 2443-9.
27. Laukens D, Georges M, Libioulle C et al. Evidence for significant overlap between common risk variants for Crohns' disease and ankylosing spondylitis. PLoS ONE 2010; 5: e13795.
28. Dupont AW. Post-infectious irritable bowel syndrome. Curr Gastroenterol Rep 2007; 9: 378-84.
29. Tana C, Umesaki Y, Imaoka A, Handa T, Kanazawa M, Fukudo S. Altered profiles of intestinal microbiota and organic acids may be the origin of symptoms in irritable bowel syndrome. Neurogastroenterol Motil 2010; 22: 512-5.